Literature DB >> 8994777

Consequences of bacterial resistance to antibiotics in medical practice.

J F Acar1.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 8994777     DOI： 10.1093/clinids/24.supplement_1.s17

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  23 in total

1.  Role of global surveillance in combating bacterial resistance.

Authors:  A Marchese; G C Schito
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Rotation of antimicrobial therapy in the intensive care unit: impact on incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria.

Authors:  E Raineri; L Crema; S Dal Zoppo; A Acquarolo; A Pan; G Carnevale; F Albertario; A Candiani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-04       Impact factor: 3.267

3.  Ciprofloxacin or imipenem use correlates with resistance in Pseudomonas aeruginosa.

Authors:  G G Zhanel; L E Nicolle; A S Gin; J Karlowsky; A Kabani; D J Hoban
Journal:  Can J Infect Dis       Date:  1998-11

4.  Comparison of in vitro activities of fluoroquinolone-like 2,4- and 1,3-diones.

Authors:  Lisa M Oppegard; Kathryn R Streck; Jonathan D Rosen; Heidi A Schwanz; Karl Drlica; Robert J Kerns; Hiroshi Hiasa
Journal:  Antimicrob Agents Chemother       Date:  2010-04-19       Impact factor: 5.191

5.  Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance.

Authors:  I Chopra; M Roberts
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

6.  Prescribing practices and attitudes toward giving children antibiotics.

Authors:  E Paluck; D Katzenstein; C J Frankish; C P Herbert; R Milner; D Speert; K Chambers
Journal:  Can Fam Physician       Date:  2001-03       Impact factor: 3.275

7.  Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model.

Authors:  R E Lewis; B C Lund; M E Klepser; E J Ernst; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

8.  Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in adult surgical cancer patients.

Authors:  E Velasco; M Soares; R Byington; C A S Martins; M Schirmer; L M C Dias; V M S Gonçalves
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-07-28       Impact factor: 3.267

9.  Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes.

Authors:  A Abbo; Y Carmeli; S Navon-Venezia; Y Siegman-Igra; M J Schwaber
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11       Impact factor: 3.267

Review 10.  Sequencing-based methods and resources to study antimicrobial resistance.

Authors:  Manish Boolchandani; Alaric W D'Souza; Gautam Dantas
Journal:  Nat Rev Genet       Date:  2019-06       Impact factor: 53.242
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.